Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 4 days agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 4 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 3 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 4 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 4 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 3 days agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 4 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 4 days agos first-quarter expectations Thursday. The Covid vaccine maker came out of the March quarter with a...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 4 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via AOL· 4 days ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...